Eduardo Villablanca group

Eduardo Villablanca

Eduardo Villablanca
Assistant professor

” Our research program seeks to dissect the complex dynamics of host-environment interactions required to sustain intestinal immune homeostasis and how breakdown in these interactions may lead to inflammatory bowel diseases (IBD). Although genome wide association studies (GWAS) have been instrumental in associating genetic variants/polymorphisms with IBD, assigning causality to these variants in IBD pathogenesis has […] ”


Clinical Immunology and Allergy

Karin Lore_1

Karin Loré

” Understanding mechanisms of vaccination Few medical inventions have affected and saved so many lives as vaccines against infectious diseases. The challenges we are facing today with developing effective vaccines to several of the world’s most serious infectious diseases (HIV-1/AIDS, malaria, tuberculosis) epidemics as well as designing therapeutic vaccines to tumors and/or allergies require a much […] ”

+46-73-7121551 or +46-8-524 87672

Translational cardiology, Bäck

Magnus Bäck

Magnus Bäck

” Our research applies translational aspects to study mechanisms of cardiovascular disease and identify novel potential therapeutic targets. Based at the Center for Molecular Medicine at Karolinska Institutet and the Cardiology Department of Karolinska University Hospital, we integrate studies of human tissues and cells using advanced molecular biology with the clinical characteristics of disease. We also […] ”

+46 8 517 764 19

Clinical Neuroimmunology - Fogdell-Hahn

Anna Fogdell Hahn_3_liten

Anna Fogdell-Hahn

” Part of our research focus is to understand the disease mechanism behind the autoimmune reaction in MS and a possible viral etiology. Our hypothesis is that specific autoimmunity is triggered by immune response against host proteins incorporated into viral particles. We are therefore interested in common viruses that can establish latency and reactivate within the […] ”

+46 8 517 702 51

Therapeutic immune design

Hans Grönlund_1

Hans Grönlund
PhD, Associate professor

” Our goal is to improve the quality of life for patients with chronic inflammatory disease or cancer. The approach is “translational”, i.e. we aim to bring research results from the lab to clinical application, in the form of improved diagnostic tools and curative treatments. We work within the following research areas: Multiple sclerosis (MS) Our […] ”

+46-8-517 730 26

Pediatric rheumatology


Helena Erlandsson Harris

” Our research aims at improving the knowledge regarding disease-causing mechanisms active during chronic inflammatory joint disease (arthritis) in children as well as in adults. The obtained knowledge forms a basis for the development of new, targeted anti-rheumatic therapy. We are especially interested in the group of self molecules termed Alarmins. These are molecules with defined […] ”

+46 8 517 767 46
L8:04, Room 067

Diabetes immunology


Sanjeevi Carani
Forskare, MD, PhD

” Our group is involved in studies of immunology and hereditary factors of the immunity of Autoimmune Diabetes (AD). AD can be divided into: (i) Type 1 Diabetes occurring predominantly in children and less in older individuals, and (ii) Latent Autoimmune Diabetes in Adults (LADA), predominantly occurring in older individuals. Type 1 Diabetes shares several common features […] ”

+46 8 517 762 54

Molecular autoimmunity


Marie Wahren Herlenius
Professor, MD

” Autoimmune disorders are a major cause of disease and disability, affecting more than 5% of the population. Sjögren’s syndrome is a rheumatic autoimmune condition affecting salivary and lacrimal glands, and in which Ro52/SSA is a major autoantigen. We have chosen the approach of studying both the biologic function of the target autoantigen Ro52, and the […] ”

+46 8 517 762 45
L8:04, Room 067

Multiple sclerosis (MS)

JanHillert kopia

Jan Hillert
Professor, MD

” Multiple sclerosis, commonly known as MS, is a chronic inflammatory disease of the central nervous system which, if left untreated, causes increasing disability for over one million people worldwide. MS treatments are so far partially effective or hampered by side effects, leaving a great clinical need for intensified research on disease mechanisms and novel therapeutics. […] ”

+46 8 517 769 73, +46 8 517 760 97


Tomas Olsson 2

Tomas Olsson
Professor, MD

” Our main research programme encompass identification of genes that predispose to both human MS and its experimental counterpart (EAE), attempting to elucidate the molecular and cellular mechanisms that lead to disease development. Our related programmes compliment this strategy by focusing on why nerve cells die and how stem cells can be used to heal neuroimmunological […] ”

+46 8 517 762 42
L8:04 room 062

Clinical chemistry


Thomas Renné
Professor, MD

” Combinations of proinflammatory and procoagulant reactions are the unifying principle for a variety of disorders affecting the cardiovascular system. Factor XII (FXII, Hageman factor) is a plasma protease that initiates the contact system. This system starts a cascade of procoagulant and proinflammatory reactions via the intrinsic pathway of coagulation, and the bradykinin-producing kallikrein-kinin system, respectively. […] ”

+46 8 517 733 90, +46 707 73 01 09

Applied Immunology and immunotherapy


Robert Harris

”   IMAGINE a time when we could end the suffering of individuals with chronic inflammatory diseases. Realising that dream is what we must do NOW BECAUSE we have the knowledge, drive and vision to make it happen. We conduct a strongly interconnected research programme aimed at using knowledge gained from projects in basic science to […] ”

+46 8 517 765 61
L8:04, Room 062

Team Natalia Landázuri


Natalia Landázuri Sáenz
Assistant Professor

” Our line of research focuses on adult stem cells in the context of health and disease. We are interested in adult stem cell as tools to design novel regenerative therapies to treat ischemia and vascular injury. We are also interested in how stem cells can impact the development of tumors through mechanisms similar to those […] ”

+46 8 517 798 44

Leukocyte-Endothelial Interactions in Large Vessel Biology

Einar Eriksson

Einar Eriksson
MD, PhD, Associate Professor, Affiliated

” Inflammatory recruitment of blood cells to the vascular wall is of importance in large vessel pathology including atherosclerosis, arthritis, and intimal hyperplasia in response to vascular intervention. We use various microscopic techniques on live mice and whole mount tissues to study the mechanisms that guide transition of leukocytes from free flow to extravasation. At present, […] ”

+46 8 517 700 00

Innate immunity in atherosclerosis – Yan


Zhong-Qun Yan
MD, PhD, Docent

” Innate signaling pathways of the immune system are important for atherosclerotic disease. Among other cell types, we are particularly interested in the macrophage and its function in the disease process.   If you would like to support this area of research you could do that by using the following accounts: BG 628-4418 PG 514114-8 State: […] ”

+4 68 517 732 07
CMM L8:03

Stemcells and inflammation - Brundin


Lou Brundin

” The effects of inflammation on neural stem cells During injuries and inflammation in the central nervous system neural stem/progenitor cells are activated to migrate into the injury. A limited replacement of the injured tissue can be achieved by differentiation of the progenitor cells. The replacement of oligodendrocytes which occurs in the early phases of multiple […] ”

+46 8 517 765 61
R3:04, neurology clinic

Smoking-induced autoimmunity


Johan Öckinger
PhD, Senior Postdoc

” Cigarette smoking has been linked to risk of disease or to disease phenotype in a number of autoimmune disorders, such as rheumatoid arthritis and multiple sclerosis. The local microenvironment, such as that present in the lung, may determine which antigens are presented, and also direct the alternative fates of effector and regulatory T cell subsets […] ”

+46 8 517 706 66

Skin Immunology - Eidsmo

Liv Eidsmo

Liv Eidsmo

” Psoriasis is a T cell driven inflammatory disease of primarily the skin that affects 2-3 % of the Swedish population. Effective treatment suppresses the chronic inflammation but cure is currently not feasible. Psoriasis often return in the same areas of the skin and it seems that resolved skin contains a hidden disease memory. We aim […] ”

+46 8 517 721 58

HIV - Broliden

Kristina Broliden

Kristina Broliden
Professor, MD, PhD

” Genital mucosal barriers against HIV-infection Environmental factors including hormonal contraceptive use, genital infections and seminal fluid itself affect the susceptibility to HIV infection as demonstrated in epidemiological and experimental studies. The molecular mechanisms behind these findings are however poorly defined. Our group aims to study how the human female genital tract is affected by these […] ”

+46 8 517 760 45

Cellular immunology and rheumatic diseases - Malmström

Vivi copy

Vivianne Malmström

” Inflammatory rheumatic disease – importance and contribution of B and T cell subsets Today inflammatory rheumatic diseases like RA (rheumatoid arthritis) can be treated with different biological therapies including those who target B and T cells. Still, we do not understand precisely how T and B cell subsets contribute to disease. In the cellular immunology/rheumatology […] ”

+46 8 517 756 09

The Pathobiology of Autoantibodies in Rheumatoid Arthritis - Lundberg

Karin Lundberg

Karin Lundberg

” Our research aims to increase our understanding of the pathobiology underpinning the anti-citrullinated protein/peptide antibody (ACPA) response in rheumatoid arthritis (RA). Specifically, we investigate the hypothesis that the periodontal bacterium Porphyromonas gingivalis – a major cause of chronic periodontitis – is driving disease in a subset of RA, by mediating loss of tolerance to citrullinated […] ”

08-517 765 60

CMM Research Groups




Cardiovascular and Metabolic Diseases